Filter by: patients
Home > Community Treatment Reports and Side Effects > Yohimbine Treatment Report
What is Yohimbine?

Yohimbine hydrochloride is used for the treatment of SSRI antidepressant-induced sexual dysfunction; weight loss; impotence; and may have activity as an aphrodisiac. Yohimbine chloride is used to treat erectile dysfunction.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
dietary supplement 1 0
Other 1 1 Efficacy_major
Sexual dysfunction 1 1 Efficacy_slight

See all 2 patients currently taking Yohimbine

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 1
Mild
 0
None
 1

Commonly reported side effects, conditions, and hospitalizations associated with Yohimbine

Nervousness 1

Reported Dosages

  5mg as needed 2 other daily
  1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Yohimbine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 1   Did not seem to work: 100%

See all 1 patient who’ve stopped taking Yohimbine

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Yohimbine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Taking Yohimbine

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Yohimbine

Always
 0 0%
Usually
 2 100%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Yohimbine

Very
 0 0%
Somewhat
 0 0%
A little
 1 50%
Not at all
 1 50%

Cost

Paid out of pocket

Cost of Yohimbine

$200+
 0 0%
$100-199
 0 0%
$50-99
 1 50%
$25-49
 0 0%
< $25
 1 50%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 25, 2012.